Jeffrey Smith

Jeffrey Smith

Corporate Officer/Principal chez
American College of Rheumatology

Fortune : 698 147 $ au 30/06/2026

67 ans
Health Technology
Commercial Services
Consumer Non-Durables

Profil

Jeffrey T.
L.
Smith
was the founder of Lundbeck Seattle BioPharmaceuticals, Inc., founded in 2004, where the title held was Managing Director-Ireland from 2017 to 2019.
Dr. Smith currently holds the position of Research Member at the American College of Rheumatology since 2013.
Former jobs include Medical Director at Simbec Research Ltd. from 1997 to 1999; Senior Director-Medical Research at Celltech R&D, Inc. from 1999 to 2004; Senior Clinical Physician at Procter & Gamble Co. from 1994 to 1995; Head-Clinical Pharmacology at Hoechst Marion Roussel Ltd. (United Kingdom) from 1995 to 1997; Chief Medical Officer & Executive Vice President at Zymeworks, Inc. from 2024 to 2026; and Senior Research Physician at Glaxo Research Laboratories from 1989 to 1994.
Education includes undergraduate and doctorate degrees from the University of London.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
12/01/2026 26 708 ( 0,04% ) 698 147 $ 30/06/2026

Postes actifs de Jeffrey Smith

SociétésPosteDébut
Corporate Officer/Principal -

Anciens postes connus de Jeffrey Smith

SociétésPosteFin
ZYMEWORKS INC. Directeur Technique/Scientifique/R&D 31/01/2026
ALDER BIOPHARMACEUTICALS, INC. Fondateur 10/10/2019
Corporate Officer/Principal 01/01/2004
Directeur Technique/Scientifique/R&D 01/01/1999
Corporate Officer/Principal 01/01/1997
Voir l'expérience en détail de Jeffrey Smith

Formation de Jeffrey Smith

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

56

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées9

Consumer Non-Durables

Health Technology

Commercial Services

Consumer Services

Health Technology

Retail Trade

Commercial Services

Glaxo Research Laboratories

Health Technology

  1. Bourse
  2. Insiders
  3. Jeffrey Smith